NCT06835374

Brief Summary

Achalasia is a neuro-degenerative disorder marked by changes in the peristalsis of the esophagus and the lack of relaxation in the lower esophageal sphincter (LES), thought to be due to damage to the myenteric plexus with an unknown cause.1 Per-oral endoscopic myotomy (POEM) is an established endoscopic treatment modality for achalasia. Leading gastrointestinal (GI) societies endorse POEM as one of the primary treatment option for achalasia.This study aims to characterize and compare the morphological characteristics of reflux related erosions after the POEM procedures versus those in cases without esophageal motility disorders. Data collection

  1. 1.Demographic characteristics: Age, gender, type of achalasia
  2. 2.Manometry findings (pre and post POEM): integrated relaxation pressure, lower esophageal sphincter pressure
  3. 3.Comorbidities
  4. 4.Medications
  5. 5.Eckardt score: before procedure and 3-months after Procedure
  6. 6.POEM procedure details: length of esophageal and gastric myotomy, adverse events, length of hospital stay
  7. 7.Evaluation at 3-months Symptom: standardized questionnaire (GERDQ) Endoscopy: grade of esophagitis Erosions vs ulcers Dimension of erosions Anatomical location (according to clock)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2025

Completed
Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

February 8, 2025

Last Update Submit

February 13, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • comparison of reflux esophagitis in cases who undergo POEM procedure versus those without esophageal motility disorders

    Reflux esophagitis can be calculated as grade B category (red colour scar found in esophagus mucosa) during endoscopy procedure

    3 months

  • Assessment of the , esophageal acid exposure

    esophageal acid exposure is a value indicates higher reflux can be calculated in ph impedence report

    6 months

Study Arms (2)

Assesment of reflux esophagitis in cases with esophageal motility

ACTIVE COMPARATOR

Reflux esophagitis can be found in Endoscopy report.

Procedure: Per oral endoscopy myotomy (Per oral endoscopy myotomy)

Assesment of reflux esophagitis in cases without esophageal motility

PLACEBO COMPARATOR

Reflux esophagitis can be found in cases in normal gastroesophageal reflux disease condition patients

Procedure: Endoscopy procedure

Interventions

POEM is the procedure to reduce the symptoms of dysphagia, regurgitation.

Assesment of reflux esophagitis in cases with esophageal motility

Endoscopy procedure is required to rule out type of reflux disease

Assesment of reflux esophagitis in cases without esophageal motility

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥18y,
  • confirmed diagnosis of Achalasia,
  • No contraindication to POEM,
  • erosive esophagitis on endoscopy

You may not qualify if:

  • Non-esophageal esophageal motility disorders,
  • Treatment other than POEM,
  • current PPI use before assessment for GERD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian Institute of Gastroenterology Hospital

Hyderabad, Telangana, 500082, India

RECRUITING

MeSH Terms

Conditions

Esophageal Diseases

Interventions

Endoscopy

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Zaheer Nabi Dr Mohammed, MBBS MD

    AIG Hospitals

    PRINCIPAL INVESTIGATOR
  • Chinmay Dr Hegde, MBBS MD

    AIG Hospitals

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rajesh Goud Mr Maragoni, M.Pharm, MBA

CONTACT

Zaheer Nabi Dr Mohammed, MBBS MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

February 8, 2025

First Posted

February 19, 2025

Study Start

May 11, 2024

Primary Completion

February 28, 2025

Study Completion

May 10, 2025

Last Updated

February 19, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations